Tumor angiogenesis: Molecular pathology, therapeutic targeting, and imaging
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Academic Radiology
- Vol. 7 (10) , 800-811
- https://doi.org/10.1016/s1076-6332(00)80629-7
Abstract
No abstract availableThis publication has 109 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsPublished by Elsevier ,2004
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesisEuropean Journal Of Cancer, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971